Current Status and Future Promise of the Human Microbiome
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
The human-associated microbiota is diverse, varies between individuals and body sites, and is important in human health. Microbes in human body play an essential role in immunity, health, and disease. The human microbiome has been studies using the advances of next-generation sequencing and its metagenomic applications. This has allowed investigation of the microbial composition in the human body, and identification of the functional genes expressed by this microbial community. The gut microbes have been found to be the most diverse and constitute the densest cell number in the human microbiota; thus, it has been studied more than other sites. Early results have indicated that the imbalances in gut microbiota are related to numerous disorders, such as inflammatory bowel disease, colorectal cancer, diabetes, and atopy. Clinical therapy involving modulating of the microbiota, such as fecal transplantation, has been applied, and its effects investigated in some diseases. Human microbiome studies form part of human genome projects, and understanding gleaned from studies increase the possibility of various applications including personalized medicine. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 71∼79)
Abstract
The human-associated microbiota is diverse, varies between individuals and body sites, and is important in human health. Microbes in human body play an essential role in immunity, health, and disease. The human microbiome has been studies using the advances of next-generation sequencing and its metagenomic applications. This has allowed investigation of the microbial composition in the human body, and identification of the functional genes expressed by this microbial community. The gut microbes have been found to be the most diverse and constitute the densest cell number in the human microbiota; thus, it has been studied more than other sites. Early results have indicated that the imbalances in gut microbiota are related to numerous disorders, such as inflammatory bowel disease, colorectal cancer, diabetes, and atopy. Clinical therapy involving modulating of the microbiota, such as fecal transplantation, has been applied, and its effects investigated in some diseases. Human microbiome studies form part of human genome projects, and understanding gleaned from studies increase the possibility of various applications including personalized medicine. (Pediatr Gastroenterol Hepatol Nutr 2013; 16: 71∼79)
참고문헌 (61)
- Turnbaugh PJ, "The human microbiome project", Nature, 449, pp.804~810 (2007)
- Maynard CL, "Reciprocal interactions of the intestinal microbiota and immune system", Nature, 489, pp.231~241 (2012)
- Krznarić Z, "Gut microbiota and obesity", Dig Dis, 30, pp.196~200 (2012)
- Aslam Z, "Too much bacteria still unculturable", Crop Environ, 1, pp.59~60 (2010)
- Handelsman J, "Molecular biological access to the chemistry of unknown soil microbes: a new frontier for natural products", Chem Biol, 5, pp.R245~249 (1998)
- Eckburg PB, "Diversity of the human intestinal microbial flora", Science, 308, pp.1635~1638 (2005)
- Turnbaugh PJ, "A core gut microbiome in obese and lean twins", Nature, 457, pp.480~484 (2009)
- Costello EK, "Bacterial community variation in human body habitats across space and time", Science, 326, pp.1694~1697 (2009)
- Scholz MB, "Next generation sequencing and bioinformatic bottlenecks: the current state of metagenomic data analysis", Curr Opin Biotechnol, 23, pp.9~15 (2012)
- Tremaroli V, "Functional interactions between the gut microbiota and host metabolism", Nature, 489, pp.242~249 (2012)
- von Wintzingerode F, "Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis", FEMS Microbiol Rev, 21, pp.213~229 (1997)
- Gosalbes MJ, "Metatranscriptomic approach to analyze the functional human gut microbiota", PLoS One, 6, pp.e17447~ (2011)
- Verberkmoes NC, "Shotgun metaproteomics of the human distal gut microbiota", ISME J, 3, pp.179~189 (2009)
- Turnbaugh PJ, "An invitation to the marriage of metagenomics and metabolomics", Cell, 134, pp.708~713 (2008)
- Methé BA, "Human Microbiome Project Consortium. A framework for human microbiome research", Nature, 486, pp.215~221 (2012)
- Huttenhower C, "Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome", Nature, 486, pp.207~214 (2012)
- Bäckhed F, "Host-bacterial mutualism in the human intestine", Science, 307, pp.1915~1920 (2005)
- Hooper LV, "How host-microbial interactions shape the nutrient environment of the mammalian intestine", Annu Rev Nutr, 22, pp.283~307 (2002)
- Ley RE, "Obesity and the human microbiome", Curr Opin Gastroenterol, 26, pp.5~11 (2010)
- Qin J, "A human gut microbial gene catalogue established by metagenomic sequencing", Nature, 464, pp.59~65 (2010)
- Arumugam M, "Enterotypes of the human gut microbiome", Nature, 473, pp.174~180 (2011)
- Ley RE, "Microbial ecology: human gut microbes associated with obesity", Nature, 444, pp.1022~1023 (2006)
- Lepage P, "A metagenomic insight into our gut's microbiome", Gut, 62, pp.146~158 (2013)
- Manichanh C, "A comparison of random sequence reads versus 16S rDNA sequences for estimating the biodiversity of a metagenomic library", Nucleic Acids Res, 36, pp.5180~5188 (2008)
- Yatsunenko T, "Human gut microbiome viewed across age and geography", Nature, 486, pp.222~227 (2012)
- Ursell LK, "The interpersonal and intrapersonal diversity of human-associated microbiota inkey body sites", J Allergy Clin Immunol, 129, pp.1204~1208 (2012)
- Sartor RB, "Microbial influences in inflammatory bowel diseases", Gastroenterology, 134, pp.577~594 (2008)
- Dominguez-Bello MG, "Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns", Proc Natl Acad Sci, 107, pp.11971~11975 (2010)
- Koenig JE, "Succession of microbial consortia in the developing infant gut microbiome", Proc Natl Acad Sci, 108(1), pp.4578~4585 (2011)
- Harmsen HJ, "Analysis of intestinal flora development in breast-fed and formula- fed infants by using molecular identification and detection methods", J Pediatr Gastroenterol Nutr, 30, pp.61~67 (2000)
- Kozyrskyj AL, "Increased risk of childhood asthma from antibiotic use in early life", Chest, 131, pp.1753~1759 (2007)
- Russell SL, "Early life antibiotic- driven changes in microbiota enhance susceptibility to allergic asthma", EMBO Rep, 13, pp.440~447 (2012)
- Hviid A, "Antibiotic use and inflammatory bowel diseases in childhood", Gut, 60, pp.49~54 (2011)
- Lee S, "Comparison of the gut microbiotas of healthy adult twins living in South Korea and the United States", Appl Environ Microbiol, 77, pp.7433~7437 (2011)
- Young VB, "The intestinal microbiota in health and disease", Curr Opin Gastroenterol, 28, pp.63~69 (2012)
- DuPont AW, "The intestinal microbiota and chronic disorders of the gut", Nat Rev Gastroenterol Hepatol, 8, pp.523~531 (2011)
- Tamboli CP, "Dysbiosis in inflammatory bowel disease", Gut, 53, pp.1~4 (2004)
- Blumberg R, "Microbiota, disease, and back to health: a metastable journey", Sci Transl Med, 4, pp.137~137 (2012)
- Kuczynski J, "Experimental and analytical tools for studying the human microbiome", Nat Rev Genet, 13, pp.47~58 (2011)
- McLaughlin SD, "The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing", Ann Surg, 252, pp.90~98 (2010)
- Manichanh C, "Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach", Gut, 55, pp.205~211 (2006)
- Lepage P, "Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis", Gastroenterology, 141, pp.227~236 (2011)
- Lupp C, "Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae", Cell Host Microbe, 2, pp.119~129 (2007)
- Garrett WS, "Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis", Cell Host Microbe, 8, pp.292~300 (2010)
- Mai V, "Fecal microbiota in premature infants prior to necrotizing enterocolitis", PLoS One, 6, pp.e20647~ (2011)
- Ramakrishna BS, "Colonic dysfunction in acute diarrhoea: the role of luminal short chain fatty acids", Gut, 34, pp.1215~1218 (1993)
- Sokol H, "Low counts of Faecalibacterium prausnitzii in colitis microbiota", Inflamm Bowel Dis, 15, pp.1183~1189 (2009)
- Carvalho FA, "Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice", Cell Host Microbe, 12, pp.139~152 (2012)
- Biasucci G, "qMode of delivery affects the bacterial community in the newborn gut", Early Hum Dev 2010;86 Suppl, 86(1), pp.13~15 (2010)
- Ó Cuív P, "The effects from DNA extraction methods on the evaluation of microbial diversity associated with human colonic tissue", Microb Ecol, 61, pp.353~362 (2011)
- Jernberg C, "Long-term impacts of antibiotic exposure on the human intestinal microbiota", Microbiology, 156, pp.3216~3223 (2010)
- Dethlefsen L, "Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation", Proc Natl Acad Sci, 108(Suppl 1), pp.4554~4561 (2011)
- Reid G, "icrobiota restoration: natural and supplemented recovery of human microbial communities", Nat Rev Microbiol, 9, pp.27~38 (2011)
- Deshpande G, "Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates", Pediatrics, 125, pp.921~930 (2010)
- Kale-Pradhan PB, "Role of Lactobacillus in the prevention of antibiotic-associated diarrhea: a meta-analysis", Pharmacotherapy, 30, pp.119~126 (2010)
- Hopkins MJ, "Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro", Appl Environ Microbiol, 69, pp.1920~1927 (2003)
- Kassam Z, "Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis", Am J Gastroenterol, 108, pp.500~508 (2013)
- Kachrimanidou M, "Clostridium difficile infection: a comprehensive review", Crit Rev Microbiol, 37, pp.178~187 (2011)
- Bakken JS, "Fecal Microbiota Transplantation Workgroup. Treating Clostridium difficile infection with fecal microbiota transplantation", Clin Gastroenterol Hepatol, 9, pp.1044~1049 (2011)
- Borody TJ, "Fecal microbiota transplantation: a new standard treatment option for Clostridium difficile infection", Expert Rev Anti Infect Ther, 11, pp.447~449 (2013)
- Borody TJ, "Fecal microbiota transplantation and emerging applications", Nat Rev Gastroenterol Hepatol, 9, pp.88~96 (2011)
